Volume 68, Issue 6, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Volume 52, Issue 1, Pages (July 2007)
Advertisements

Volume 67, Issue 1, Pages (January 2015)
Pitié-Salpêtriètre Hospital Assistance-Publique Hôpitaux de Paris
Volume 68, Issue 6, Pages (December 2015)
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer  Fan Mo, Dong Lin, Mandeep Takhar, Varune Rohan Ramnarine, Xin Dong, Robert.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 69, Issue 6, Pages (June 2016)
Inflammatory Protein Serum Amyloid A1 Marks a Subset of Conventional Renal Cell Carcinomas with Fatal Outcome  Claudia Paret, Zorica Schön, Adrianna Szponar,
Volume 52, Issue 1, Pages (July 2007)
Volume 72, Issue 1, Pages (July 2017)
Gene expression of prostanoid forming enzymes along the rat nephron1
Volume 69, Issue 6, Pages (June 2016)
Volume 52, Issue 3, Pages (September 2007)
Volume 72, Issue 3, Pages (September 2017)
Volume 71, Issue 2, Pages (February 2017)
Volume 67, Issue 1, Pages (January 2015)
Volume 51, Issue 5, Pages (May 2007)
Volume 68, Issue 5, Pages (November 2015)
Volume 59, Issue 2, Pages (February 2011)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 78, Issue 2, Pages (July 2010)
Volume 66, Issue 2, Pages (August 2014)
Volume 67, Issue 4, Pages (April 2015)
Volume 52, Issue 5, Pages (November 2007)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Volume 66, Issue 5, Pages (November 2014)
Volume 70, Issue 5, Pages (November 2016)
Volume 52, Issue 1, Pages (July 2007)
Next-generation Sequencing of Urologic Cancers: Next Is Now
On Molecular Classification of Bladder Cancer: Out of One, Many
Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma  Viktor Grünwald, Xun Lin, Daniel Kalanovic,
Volume 74, Issue 5, Pages (November 2018)
Volume 52, Issue 3, Pages (September 2007)
European Urology Oncology
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma  Francesco Gatto, Kyle A. Blum, Seyedeh Shaghayegh.
Volume 71, Issue 6, Pages (June 2017)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours  Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.
Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy  Kerstin Junker, Sebastian Hölters,
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 64, Issue 6, Pages (December 2013)
Volume 66, Issue 5, Pages (November 2014)
Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E
Volume 55, Issue 4, Pages (April 1999)
Volume 63, Issue 3, Pages (March 2013)
Volume 72, Issue 4, Pages (October 2017)
Volume 61, Issue 6, Pages (June 2012)
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 53, Issue 1, Pages (January 2008)
Volume 58, Issue 1, Pages (July 2010)
Volume 17, Issue 1, Pages (January 2010)
Molecular Subtypes of Non-muscle Invasive Bladder Cancer
Molecular Classification of Renal Tumors by Gene Expression Profiling
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer  Meng Zhou, Long Hu, Zicheng.
Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest  Christopher Lau, MD, Padraic O’Malley, MD, Mario.
Volume 74, Issue 3, Pages (September 2018)
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
Volume 74, Issue 6, Pages (December 2018)
Acute renal failure: From renal physiology to the renal transcriptome
Volume 142, Issue 3, Pages (September 2016)
Insulin resistance and hypertension: new insights
Volume 26, Issue 12, Pages e5 (March 2019)
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Structure of the nephron.
Highly metastatic PDAC cells have a unique gene signature, which is not preserved in metastases but predicts poor patient outcome. Highly metastatic PDAC.
Fig. 1. FAM83H over-expression is associated with poor prognosis of CC
Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.
Presentation transcript:

Volume 68, Issue 6, Pages 1016-1020 (December 2015) Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron  Florian Büttner, Stefan Winter, Steffen Rausch, Anna Reustle, Stephan Kruck, Kerstin Junker, Arnulf Stenzl, Abbas Agaimy, Arndt Hartmann, Jens Bedke, Matthias Schwab, Elke Schaeffeler  European Urology  Volume 68, Issue 6, Pages 1016-1020 (December 2015) DOI: 10.1016/j.eururo.2015.05.045 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 (A) Clustering of renal cell carcinoma (RCC) tumours by means of gene expression correlation between profiles of tumours and profiles of human nephron cell types. Interprofile Spearman rank correlation coefficients (IPCs) were calculated using 97 genes that differentiate nephron regions (glomeruli, initial and terminal part of proximal tubule [S1/S3], medullary and cortical thick ascending limbs of the loop of Henle, distal convoluted tubules, and cortical and outer medullary collecting ducts). The heat map shows z scores obtained by centering and standardising the IPCs per the Cancer Genome Atlas (TCGA) sample. Samples were clustered per tumour entity using a resampling-based consensus clustering approach. Resulting clusters are color coded (see color bar on the left). (B–D) Cancer-specific survival (CSS) of clear cell renal cell carcinoma (ccRCC) tumours predicted by the S3-score. Kaplan-Meier curves showing CSS of (B) the ccRCC cohort (n=463) and (C) the metastatic (n=76) and (D) nonmetastatic subsets (n=374). Groups are defined by cut-offs of the S3-score, as determined by conditional interference tree models. (E) S3-score significantly improves established prediction scores. Chi-square statistic values depict the improvement of the model likelihood when S3-score (red) and ccA/ccB signature (blue) are sequentially added to the Cox model initially including only the stage, size, grade, and necrosis (SSIGN) score. The chi-square statistic comparing the initial model with the null model is given as baseline value (177.73). *p<0.05, **p<0.01, ***p<0.001. (F) Validation of the S3-score in an independent study cohort. Kaplan-Meier curves showing CSS in an independent cohort of ccRCC tumours (n=139) predicted by the S3-score. Groups are defined by the same cut-off value of the S3-score (−0.167) as in (B). Detailed information on statistical methods is given in the supplementary data. CCD=cortical collecting ducts; ccRCC=clear cell renal cell carcinoma; chRCC=chromophobe renal cell carcinoma; CI=confidence interval; CSS=cancer-specific survival; cTAL=cortical thick ascending limbs of the loop of Henle; DCT=distal convoluted tubules; Glom=glomeruli; HR=hazard ratio; IPC=interprofile Spearman rank correlation coefficient; mTAL=medullary thick ascending limbs of the loop of Henle; OMCD=outer medullary collecting ducts; pRCC=papillary renal cell carcinoma; SSIGN=stage, size, grade, and necrosis (score); TCGA=The Cancer Genome Atlas. European Urology 2015 68, 1016-1020DOI: (10.1016/j.eururo.2015.05.045) Copyright © 2015 European Association of Urology Terms and Conditions